ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 4: Endocrine, nutritional and metabolic diseasesE31

E31

Billable

Polyglandular dysfunction

Chapter 4:Endocrine, nutritional and metabolic diseases

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E31 is a billable code used to indicate a diagnosis of polyglandular dysfunction.

Key Diagnostic Point:

Polyglandular dysfunction refers to a group of disorders characterized by the simultaneous or sequential dysfunction of two or more endocrine glands. This condition often manifests in various ways, including hormonal imbalances that can lead to growth abnormalities, puberty disorders, and immune system dysfunctions. The thymus gland, which plays a crucial role in the immune system, can also be affected, leading to increased susceptibility to infections and autoimmune diseases. In children and adolescents, polyglandular dysfunction can result in delayed or precocious puberty due to the disruption of normal hormonal signaling pathways. The interplay between the affected glands can complicate the clinical picture, making diagnosis and management challenging. Accurate coding requires a thorough understanding of the patient's clinical presentation, including any associated conditions such as autoimmune disorders or growth abnormalities. The complexity of polyglandular dysfunction lies in its multifaceted nature, necessitating careful evaluation of the patient's endocrine function and related symptoms.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Multiple endocrine glands involved
  • Varied clinical presentations
  • Potential for overlapping symptoms with other conditions
  • Need for comprehensive patient history and lab results

Audit Risk Factors

  • Inadequate documentation of gland involvement
  • Failure to document associated conditions
  • Misinterpretation of lab results
  • Inconsistent coding of related symptoms

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Detailed endocrine evaluation, including hormone levels and gland function tests.

Common Clinical Scenarios

Patients presenting with unexplained growth abnormalities or delayed puberty.

Billing Considerations

Ensure comprehensive documentation of all affected glands and related symptoms.

Pediatrics

Documentation Requirements

Growth charts, developmental milestones, and family history of endocrine disorders.

Common Clinical Scenarios

Children with signs of precocious or delayed puberty.

Billing Considerations

Document any psychosocial impacts of growth abnormalities on the child.

Coding Guidelines

Inclusion Criteria

Use E31 When
  • Follow official ICD
  • 10 coding guidelines, ensuring accurate documentation of all affected glands and associated conditions
  • Include relevant lab results and clinical findings to support the diagnosis

Exclusion Criteria

Do NOT use E31 When
No specific exclusions found.

Related CPT Codes

83001CPT Code

Thyroid-stimulating hormone (TSH) test

Clinical Scenario

Used to evaluate thyroid function in suspected polyglandular dysfunction.

Documentation Requirements

Document the reason for testing and any relevant clinical findings.

Specialty Considerations

Endocrinologists should ensure comprehensive evaluation of all endocrine functions.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of polyglandular dysfunction, improving the accuracy of data collection and reimbursement processes. This specificity aids in better understanding the epidemiology of the condition.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of polyglandular dysfunction, improving the accuracy of data collection and reimbursement processes. This specificity aids in better understanding the epidemiology of the condition.

Reimbursement & Billing Impact

reimbursement processes. This specificity aids in better understanding the epidemiology of the condition.

Resources

Clinical References

  • •
    American Association of Clinical Endocrinologists

Coding & Billing References

  • •
    American Association of Clinical Endocrinologists

Frequently Asked Questions

What are the common symptoms of polyglandular dysfunction?

Common symptoms include growth abnormalities, delayed or precocious puberty, fatigue, weight changes, and signs of autoimmune disorders.